GE11 peptide modified and reduction-responsive hyaluronic acid-based nanoparticles induced higher efficacy of doxorubicin for breast carcinoma therapy

References

• CarvalhoCSantosRXCardosoSDoxorubicin: the good, the bad and the ugly effectCurr Med Chem200916253267328519548866
   PubMed Web of Science ®Google Scholar
• TacarOSriamornsakPDassCRDoxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systemsJ Pharm Pharmacol201365215717023278683
   PubMed Web of Science ®Google Scholar
• MuraSNicolasJCouvreurPStimuli-responsive nanocarriers for drug deliveryNat Mater20131211991100324150417
   PubMed Web of Science ®Google Scholar
• SamadiNvan NostrumCFVermondenTAmidiMHenninkWEMechanistic studies on the degradation and protein release characteristics of poly (lactic-co-glycolic-co-hydroxymethylglycolic acid) nanospheresBiomacromolecules20131441044105323458350
   PubMedGoogle Scholar
• LocatelliEMatteiniPSasdelliFSurface chemistry and entrapment of magnesium nanoparticles into polymeric micelles: a highly biocompatible tool for photothermal therapyChem Commun2014505877837786
   Google Scholar
• PurcellBPLobbDCharatiMBInjectable and bioresponsive hydrogels for on-demand matrix metalloproteinase inhibitionNat Mater201413665366124681647
   PubMedGoogle Scholar
• TongRTangLMaLTuCLBaumgartnerRChengJJSmart chemistry in polymeric nanomedicineChem Soc Rev201443206982701224948004
   PubMedGoogle Scholar
• BaldiGRavagliCMazzantiniFIn vivo anticancer evaluation of the hyperthermic efficacy of anti-human epidermal growth factor receptor-targeted PEG-based nanocarrier containing magnetic nanoparticlesInt J Nanomedicine201493037305625028545
   PubMed Web of Science ®Google Scholar
• NehoffHParayathNNDomanovitchLTaurinSGreishKNanomedicine for drug targeting: strategies beyond the enhanced permeability and retention effectInt J Nanomed2014925392555
   PubMed Web of Science ®Google Scholar
• HanYZhangYLiDChenYSunJKongFTransferrin-modified nanostructured lipid carriers as multifunctional nanomedicine for codelivery of DNA and doxorubicinInt J Nanomedicine201494107411525187713
   PubMed Web of Science ®Google Scholar
• AccardoAAlojLAurilioMMorelliGTesauroDReceptor binding peptides for target-selective delivery of nanoparticles encapsulated drugsInt J Nanomedicine201491537155724741304
   PubMed Web of Science ®Google Scholar
• Quang NamBLiYJangM-SDai PhuHLeeJHLeeDSRedox-and pH-sensitive polymeric micelles based on poly(beta-amino ester)-grafted disulfide methylene oxide poly(ethylene glycol) for anticancer drug deliveryMacromolecules2015481240464054
   Google Scholar
• CunXRuanSChenJA dual strategy to improve the penetration and treatment of breast cancer by combining shrinking nanoparticles with collagen depletion by losartanActa Biomater20163118619626675124
   PubMed Web of Science ®Google Scholar
• MaYNolteRJMCornelissenJJLMVirus-based nanocarriers for drug deliveryAdv Drug Deliv Rev201264981182522285585
   PubMed Web of Science ®Google Scholar
• WuLLZouYDengCChengRMengFHZhongZYIntracellular release of doxorubicin from core-crosslinked polypeptide micelles triggered by both pH and reduction conditionsBiomaterials201334215262527223570719
   PubMed Web of Science ®Google Scholar
• CiTLiTChangGYuLDingJSimply mixing with poly(ethylene glycol) enhances the fraction of the active chemical form of antitumor drugs of camptothecin familyJ Control Release2013169332933523246468
   PubMedGoogle Scholar
• CiTChenLYuLDingJTumor regression achieved by encapsulating a moderately soluble drug into a polymeric thermogelSci Rep20144547324980734
   PubMed Web of Science ®Google Scholar
• YangRAnYMiaoFLiMLiuPTangQPreparation of folic acid-conjugated, doxorubicin-loaded, magnetic bovine serum albumin nanospheres and their antitumor effects in vitro and in vivoInt J Nanomedicine201494231424325228802
   PubMed Web of Science ®Google Scholar
• ChengLHuangF-ZChengL-FGE11-modified liposomes for non-small cell lung cancer targeting: preparation, ex vitro and in vivo evaluationInt J Nanomedicine2014992193524611009
   PubMed Web of Science ®Google Scholar
• CabezaLOrtizRAriasJLEnhanced antitumor activity of doxorubicin in breast cancer through the use of poly(butylcyanoacrylate) nanoparticlesInt J Nanomed20151012911306
   PubMed Web of Science ®Google Scholar
• LiuZJiaoYWangYZhouCZhangZPolysaccharides-based nanoparticles as drug delivery systemsAdv Drug Deliv Rev200860151650166218848591
   PubMed Web of Science ®Google Scholar
• GaneshSIyerAKMorrisseyDVAmijiMMHyaluronic acid based self-assembling nanosystems for CD44 target mediated siRNA delivery to solid tumorsBiomaterials201334133489350223410679
   PubMed Web of Science ®Google Scholar
• KoganGSoltesLSternRGemeinerPHyaluronic acid: a natural biopolymer with a broad range of biomedical and industrial applicationsBiotechnol Lett2007291172517091377
   PubMed Web of Science ®Google Scholar
• OhEJParkKKimKSTarget specific and long-acting delivery of protein, peptide, and nucleotide therapeutics using hyaluronic acid derivativesJ Control Release2010141121219758573
   PubMed Web of Science ®Google Scholar
• HerrlichPSleemanJWainwrightDHow tumor cells make use of CD44Cell Adhes Commun199862–31411479823465
   PubMed Web of Science ®Google Scholar
• SternRHyaluronidases in cancer biologySemin Cancer Biol200818427528018485730
   PubMed Web of Science ®Google Scholar
• MezghraniOTangYKeXHepatocellular carcinoma dually-targeted nanoparticles for reduction triggered intracellular delivery of doxorubicinInt J Pharm2015478255356825455765
   PubMedGoogle Scholar
• SharmaGModgilASunCSinghJGrafting of cell-penetrating peptide to receptor-targeted liposomes improves their transfection efficiency and transport across blood-brain barrier modelJ Pharm Sci201210172468247822517732
   PubMed Web of Science ®Google Scholar
• SawantRRTorchilinVPChallenges in development of targeted liposomal therapeuticsAAPS J201214230331522415612
   PubMed Web of Science ®Google Scholar
• HuangSLiCArmstrongEADual targeting of EGFR and HER3 with MEHD7945A overcomes acquired resistance to EGFR inhibitors and radiationCancer Res201373282483323172311
   PubMed Web of Science ®Google Scholar
• SalomonDSBrandtRCiardielloFNormannoNEpidermal growth factor-related peptides and their receptors in human malignanciesCrit Rev Oncol/Hematol1995193183232
   PubMed Web of Science ®Google Scholar
• LiZZhaoRWuXIdentification and characterization of a novel peptide ligand of epidermal growth factor receptor for targeted delivery of therapeuticsFaseb J200519141978198516319141
   PubMed Web of Science ®Google Scholar
• ChengRFengFMengFDengCFeijenJZhongZGlutathione-responsive nano-vehicles as a promising platform for targeted intracellular drug and gene deliveryJ Control Release2011152121221295087
   PubMed Web of Science ®Google Scholar
• MengFHHenninkWEZhongZReduction-sensitive polymers and bioconjugates for biomedical applicationsBiomaterials200930122180219819200596
   PubMed Web of Science ®Google Scholar
• HuoMYuanJTaoLWeiYRedox-responsive polymers for drug delivery: from molecular design to applicationsPolym Chem20145515191528
   Google Scholar
• LiDTangXPulliBTheranostic nanoparticles based on bioreducible polyethylenimine-coated iron oxide for reduction-responsive gene delivery and magnetic resonance imagingInt J Nanomedicine201493347336125045265
   PubMed Web of Science ®Google Scholar
• LiuXWangJXuWGlutathione-degradable drug-loaded nanogel effectively and securely suppresses hepatoma in mouse modelInt J Nanomedicine2015106587660226543363
   PubMed Web of Science ®Google Scholar
• YaoCTaiZWangXReduction-responsive cross-linked stearyl peptide for effective delivery of plasmid DNAInt J Nanomedicine2015103403341626056440
   PubMed Web of Science ®Google Scholar
• SandovalMASloatBRLansakara-PDSPEGFR-targeted stearoyl gemcitabine nanoparticles show enhanced anti-tumor activityJ Control Release2012157228729621871505
   PubMed Web of Science ®Google Scholar
• HuangJBZhangHYuYBiodegradable self-assembled nanoparticles of poly (D,L-lactide-co-glycolide)/hyaluronic acid block copolymers for target delivery of docetaxel to breast cancerBiomaterials201435155056624135268
   PubMed Web of Science ®Google Scholar
• AlferievISConnollyJMLevyRJA novel mercapto-bisphosphonate as an efficient anticalcification agent for bioprosthetic tissuesJ Organomet Chem20056901025432547
   Google Scholar
• XueMGaoDChenXLLiuKQFangYNew dimeric cholesteryl-based A(LS)(2) gelators with remarkable gelling abilities: organogel formation at room temperatureJ Colloid Interf Sci20113612556564
   Google Scholar
• EllmanGLA colorimetric method for determining low concentrations of mercaptansArch Biochem Biophys195874244345013534673
   PubMed Web of Science ®Google Scholar
• WuGFangYZYangSLuptonJRTurnerNDGlutathione metabolism and its implications for healthJ Nutr2004134348949214988435
   PubMed Web of Science ®Google Scholar
• KuppusamyPLiHIlangovanGNoninvasive imaging of tumor redox status and its modification by tissue glutathione levelsCancer Res200262130731211782393
   PubMed Web of Science ®Google Scholar
• BiswasSTorchilinVPNanopreparations for organelle-specific delivery in cancerAdv Drug Deliv Rev201466264124270008
   PubMed Web of Science ®Google Scholar
• BertrandNWuJXuXKamalyNFarokhzadOCCancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biologyAdv Drug Deliv Rev20146622524270007
   PubMed Web of Science ®Google Scholar
• WeiXSenanayakeTHWarrenGVinogradovSVHyaluronic acid-based nanogel-drug conjugates with enhanced anticancer activity designed for the targeting of CD44-positive and drug-resistant tumorsBioconjugate Chem2013244658668
   PubMed Web of Science ®Google Scholar
• TorchilinVTumor delivery of macromolecular drugs based on the EPR effectAdv Drug Deliv Rev201163313113520304019
   PubMed Web of Science ®Google Scholar
• WangJYaoKWangCTangCJiangXSynthesis and drug delivery of novel amphiphilic block copolymers containing hydrophobic dehydroabietic moietyJ Mat Chem B201311723242332
   Google Scholar
• FischerDLiYXAhlemeyerBKrieglsteinJKisselTIn vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysisBiomaterials20032471121113112527253
   PubMed Web of Science ®Google Scholar
• MaSFNishikawaMKatsumiHYamashitaFHashidaMLiver targeting of catalase by cationization for prevention of acute liver failure in miceJ Control Release2006110227328216316705
   PubMed Web of Science ®Google Scholar
• KimJOKabanovAVBronichTKPolymer micelles with cross-linked polyanion core for delivery of a cationic drug doxorubicinJ Control Release2009138319720419386272
   PubMed Web of Science ®Google Scholar
• SunHGuoBChengRMengFLiuHZhongZBiodegradable micelles with sheddable poly (ethylene glycol) shells for triggered intracellular release of doxorubicinBiomaterials200930316358636619666191
   PubMed Web of Science ®Google Scholar
• ChanJMZhangLFYuetKPPLGA-lecithin-PEG core-shell nanoparticles for controlled drug deliveryBiomaterials20093081627163419111339
   PubMed Web of Science ®Google Scholar
• GewirtzDA critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicinBiochem Pharmacol199957772774110075079
   PubMed Web of Science ®Google Scholar
• ChoiKYChungHMinKHSelf-assembled hyaluronic acid nanoparticles for active tumor targetingBiomaterials201031110611419783037
   PubMed Web of Science ®Google Scholar
• PeerDKarpJMHongSFarokhzadOCMargalitRLangerRNanocarriers as an emerging platform for cancer therapyNat Nanotechnol200721275176018654426
   PubMed Web of Science ®Google Scholar
• MaedaHNakamuraHFangJThe EPR effect for macromolecular drug delivery to solid tumors: improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivoAdv Drug Deliv Rev2013651717923088862
   PubMed Web of Science ®Google Scholar
• OctaviaYTocchettiCGGabrielsonKLJanssensSCrijnsHJMoensALDoxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategiesJ Mol Cell Cardiol20125261213122522465037
   PubMed Web of Science ®Google Scholar